Dr. Christopher D. Wells, MD

Dr. Wells practices at Northwest Florida Gastroenterology Center in Panama City, Florida.

Dr. Wells' NPI, 1285618454, was assigned on December 1, 2005. Dr. Wells graduated from VCU School of Medicine in 2001. Dr. Wells holds Florida license ME0098480.

Dr. Wells' primary practice is Northwest Florida Gastroenterology Center, at 204b E 19th St, Panama City, FL 32405. The practice phone is (850) 769-7599. Dr. Wells also practices at Northwest Florida Gastroenterology Center, 204 E 19th St, Panama City, FL 32405.

Dr. Wells' primary practice is Northwest Florida Gastroenterology Center in Panama City, Florida. Dr. Wells is also affiliated with HCA Florida Gulf Coast Hospital. The medical group on file is Digestive Diseases Center. Dmand AI also links Dr. Wells to 4 more hospitals and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Wells practices, 7 sites in all. Vendor and product names are available with a free account.

Gastroenterology is Dr. Wells' primary specialty in the NPI Registry, under taxonomy code 207RG0100X. Dr. Wells is board certified in gastroenterology by the American Board of Internal Medicine. Dmand AI has Dr. Wells' licenses on file in 3 states: Florida, Arizona and Alabama.

Dmand AI lists acid reflux, acute gastroduodenitis, chronic indigestion, chronic inflammatory bowel disease (IBD), cirrhosis of the liver, colonoscopy, fatty liver and gastroduodenitis among the conditions Dr. Wells treats.

CMS data shows 17,943 Medicare services from Dr. Wells across 23 procedure codes in 2024, for 1,754 Medicare patients. Medicare paid $392,528 for them.

CMS counts 1,754 Medicare patients who saw Dr. Wells in 2024. The largest group is 65 to 74, with 880 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 7% are also on Medicaid. Their average risk score is 1.22, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Wells' median patient age at 65, with 52% women.

In 2024, Dr. Wells wrote 1,050 Medicare Part D claims for 508 patients. 78% of them were for generic drugs. CMS names the drug for 898 of them, across 21 drugs with 11 or more claims each, at $1,821,537 in total drug cost. In 2023, CMS named 1,136 claims across 21 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 92 out of 100 for Dr. Wells for performance year 2024, reported as part of a group. Dr. Wells accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Wells as offering telehealth. CMS counts 420 procedures of upper gastrointestinal (gi) endoscopy for acid reflux by Dr. Wells, more than 98% of the clinicians it reports for that procedure.

Dmand AI links 16 papers to Dr. Wells, published from 2007 to 2013. 2007 was the busiest year, with 2. The most frequent topics are Biopsy, Colonoscopy and Antidepressive Agents. Dr. Wells has published most often in Endoscopy. Dr. Wells' most frequent co-authors are Vijayan Balan, MD, Suryakanth R. Gurudu, MD and Sean Charles Mackey, MD, PhD.

CMS Open Payments shows 283 general payments to Dr. Wells from 34 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 64% of the total. Allergan Inc. paid the most, $7,780.

Dr. Wells graduated from VCU School of Medicine in 2001.

Dr. Wells is in network with 18 carriers, including Elevance, Aetna and Excellus BlueCross BlueShield. Medicare plans come from the most carriers, 12. Check the plan with the practice before a visit.